Indoor tanning ban would reduce melanoma deaths, show researchers

A ban of commercially available indoor tanning would substantially reduce deaths from melanoma, the most serious form of skin cancer, a study led  by University of Manchester researchers has concluded.

The study findings are being published to coincide with Melanoma Awareness Month.

By tracking the projected impact on the 618,000 18-year-olds living in England in 2019, the research team showed that  a ban on indoor tanning would result in 1,206 fewer cases of melanoma and  207 fewer melanoma deaths over their lifetimes . 

The study, funded by the Manchester Cancer Research Centre, brought together a multidisciplinary team needed to address the financial, social and clinical aspects of the skin cancer project.

In addition, it would result in 3,987 fewer cases of other more common types of skin cancer (squamous cell and basal cell carcinomas) which  impose a major  burden on both affected patients and the NHS. 

The study, published in the British Journal of Dermatology, also  examined the costs of a public  information campaign at the same time as the ban, and the potential savings to the NHS. 

 And the policy would also save the NHS £700,000 resulting in a Net Monetary Benefit of £10.6m with a  99% likelihood that the ban with the information campaign would be cost-effective. 

The actual impact of an indoor tanning ban, and the savings to the NHS that would accrue, would be far greater when benefits to individuals that started to use sunbeds  over the age of 18 years were also factored in.

The results build on previous studies of the effect of similar legislation on healthcare in North America, Europe and Australia and add to the growing body of evidence supporting a total ban on commercial sunbeds. 

Though the International Agency for Research in Cancer in 2009 declared that the ultraviolet radiation from commercial indoor tanning devices  causes cancer in humans , it is currently legal for anyone over the age of 18 to use indoor tanning devices  in the UK. 

Despite some evidence of decreasing use, the practice of indoor tanning is still widespread in many countries including the UK. 

In England, sunbed use is especially high in the north-west and in cities with greater social deprivation; its popularity is thought to partly explain the unusually high rates of melanoma seen among young women living in the north-west.. 

It is also estimated there are around 62,000 children under 18 currently using sunbeds in England. 

Paul Lorigan, a Professor of Oncology at The University of Manchester and Honorary Consultant Medical Oncologist at the Christie NHS Foundation Trust said: “If the NHS invested in a public health campaign to support the ban on sunbeds, we estimate that melanoma and other skin cancers would be significantly  reduced, NHS resources would be saved and deaths averted.

“It is quite clear that melanoma and keratinocyte skin cancers have a significant impact on population health and healthcare budgets, and that a proportion are attributable to indoor tanning. Anyone who has used a sunbed increases their risk of melanoma by almost 60% .

“We show quite conclusively for the first time that banning indoor tanning supported by a public health campaign would be an efficient use of healthcare resources to reduce melanoma and other skin cancers in England. 

“Our findings agree with calculations of future productivity losses that were caused by these diseases in the USA in mainly young people in 2015 after exposure to tanning devices. There the total economic losses amounted to over $US127 billion over the individuals’ lifetimes.” 

The team analysed the cost-effectiveness of the policy on the NHS using modelling to track the national cohort of 18-year-olds over their lifetimes. 

The mortality data specifically, was obtained from Office for National Statistics. They compared a nationwide ban on commercial indoor tanning combined with a public information campaign with the status quo of availability of commercial indoor tanning. 

And they calculated the expected costs, Quality Adjusted Life Years and the Net Monetary Benefit of a ban. 

Professor Adele Green from The University of Manchester and the CRUK Manchester Institute added: “We already know that indoor tanning devices are strongly linked to melanoma and other skin cancers with resulting morbidity, mortality and increased healthcare costs. 

“But policy-makers require robust economic evidence to inform decisions about a possible ban of such devices to mitigate these burdens. We feel we have succeeded in providing that evidence.” 

Susanna Daniels, CEO at Melanoma Focus said: “This research is further evidence of the negative public health impact of sunbeds. I am thrilled that Melanoma Focus are supporting this project by funding the validation of UK costs of the melanoma diagnostic and treatment pathway. 

“For individuals, sunbed use dramatically increases the risk of developing melanoma which is the deadliest form of skin cancer. The rates of melanoma skin cancer are increasing in the UK yet 86% of cases are preventable. We strongly advise the avoidance of sunbeds.”

Source link